A053030 logo

BINEX Co., Ltd. Stock Price

KOSDAQ:A053030 Community·₩466.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

A053030 Share Price Performance

₩0
-18100.00 (-100.00%)
₩0
-18100.00 (-100.00%)
Price ₩0

A053030 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with concerning outlook.

1 Risk
1 Reward

BINEX Co., Ltd. Key Details

₩165.6b

Revenue

₩121.0b

Cost of Revenue

₩44.6b

Gross Profit

₩52.3b

Other Expenses

-₩7.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-241.84
26.93%
-4.65%
42.5%
View Full Analysis

About A053030

Founded
1957
Employees
616
CEO
Hyuk-Jong Lee
WebsiteView website
www.bi-nex.co.kr

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea.

Recent A053030 News & Updates

BINEX Co., Ltd.'s (KOSDAQ:053030) Price In Tune With Revenues

Aug 20
BINEX Co., Ltd.'s (KOSDAQ:053030) Price In Tune With Revenues

Recent updates

No updates